Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Dec
3
2019
After Decades of Broad Enforcement Discretion, FDA Signals New Approach to Homeopathic Drugs Epstein Becker & Green, P.C.
Dec
3
2019
Farmers Can Now Apply for Federal USDA Hemp Production Licenses Keller and Heckman LLP
Dec
2
2019
Illinois Legislature Clarifies Employer Liability Under Cannabis Act Barnes & Thornburg LLP
Dec
2
2019
11th Circuit Rules for Plaintiffs in Class Action Lawsuit Based on Economic Loss From Purchase of ‘Worthless’ Supplements Containing DMBA – an Impermissible NDI Keller and Heckman LLP
Dec
2
2019
Key Vote in FDA Commissioner Confirmation Process Set for December 3rd Mintz
Dec
2
2019
Key Considerations for Investments in Entities Developing Innovative FDA-Regulated Products McDermott Will & Emery
Nov
30
2019
FDA Issues Warnings to 15 Companies for Illegally Selling Products Containing CBD Ward and Smith, P.A.
Nov
28
2019
Atlantic Salmon Producers Netted by DOJ Bilzin Sumberg
Nov
27
2019
FDA Won’t Enforce Pre-Market Review Requirement for E-Liquid Packaging Modified to Incorporate “Flow Restrictors” Keller and Heckman LLP
Nov
27
2019
Senator Gillibrand Announces Bill to Expand FDA’s Investigative Authorities Keller and Heckman LLP
Nov
27
2019
Broad Genus Of HCV Compounds Wasn’t Enabled Or Described McDermott Will & Emery
Nov
27
2019
Only Director May Decide Merits Of Certificate Of Correction McDermott Will & Emery
Nov
26
2019
First Indicators of FDA’s Policy Decision on CBD and Cannabis-Derived Ingredients: “Only Limited Data” and “Real Risks” Mintz
Nov
26
2019
CBD Update: FDA Takes More Aggressive Enforcement Action in Warning Letters to Companies Keller and Heckman LLP
Nov
26
2019
Ferrero successfully enforces the Tic Tac shape mark in Italy K&L Gates
Nov
25
2019
Evidence of Actual Copying Efforts May be Relevant to Secondary Indicia McDermott Will & Emery
Nov
25
2019
Real-world Evidence Of Clinical Failure Cuts Against Reasonable Expectation Of Success McDermott Will & Emery
Nov
25
2019
California Considering Further Restrictions on VOCs in Consumer Products Keller and Heckman LLP
Nov
25
2019
Congressional Committee Takes Historic Step Toward Decriminalizing Marijuana McDermott Will & Emery
Nov
25
2019
Proposed Class Action Lawsuit Alleges ‘Simply Cocoa’ and ‘Made With Real Cocoa’ are False and Deceptive Claims for Hot Chocolate That Contains Alkalized Cocoa Keller and Heckman LLP
Nov
25
2019
Compliance Requirements Heightened Under New Pharmacy Board Rules Dinsmore & Shohl LLP
Nov
22
2019
Limitations on Pre-Employment Testing for Marijuana Epstein Becker & Green, P.C.
Nov
22
2019
Mexico Creates Warning Label Requirements For Certain Foods, Beverages Sold In Mexico Barnes & Thornburg LLP
Nov
22
2019
MCDERMOTT PLUS CHECK-UP: November 22, 2019 McDermott Will & Emery
Nov
22
2019
FDA Acting Director Of Therapeutic Biologics And Biosimilars Provides Statement On Continued Efforts To Facilitate Competition In The Biologic Marketplace Bergeson & Campbell, P.C.
Nov
22
2019
FDA Works to Find Source of Multi-State Outbreak of E. coli Infections Keller and Heckman LLP
Nov
21
2019
Nuvo Pharms. v. Dr. Reddy’s Labs. – Catch 22 at the Federal Circuit? Schwegman, Lundberg & Woessner, P.A.
Nov
21
2019
New Requirements Under the Illinois Hospital Licensing Act Faegre Drinker
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins